4,118
Views
8
CrossRef citations to date
0
Altmetric
Editorial

Important decisions in choosing the pharmacotherapy for narcoleptics

, &
Pages 483-486 | Received 17 Oct 2018, Accepted 16 Dec 2018, Published online: 28 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Geoffroy Vellieux, Justine Frija-Masson, Anny Rouvel-Tallec, Xavier Drouot & Marie-Pia d’Ortho. (2021) Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report. Nature and Science of Sleep 13, pages 1669-1673.
Read now
Gaia Pellitteri, Stefano de Biase, Mariarosaria Valente & Gian Luigi Gigli. (2021) How treatable is narcolepsy with current pharmacotherapy and what does the future hold?. Expert Opinion on Pharmacotherapy 22:12, pages 1517-1520.
Read now
Stefano de Biase, Gaia Pellitteri, Gian Luigi Gigli & Mariarosaria Valente. (2021) Evaluating pitolisant as a narcolepsy treatment option. Expert Opinion on Pharmacotherapy 22:2, pages 155-162.
Read now
Jay T Guevarra, Robert Hiensch, Andrew W Varga & David M Rapoport. (2020) Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility. Nature and Science of Sleep 12, pages 709-719.
Read now
Shuang Li & Junyi Yang. (2020) Pitolisant for treating patients with narcolepsy. Expert Review of Clinical Pharmacology 13:2, pages 79-84.
Read now

Articles from other publishers (3)

Michael J. Thorpy, Danielle Hyman, Gregory S. Parks, Abby Chen, Catherine Foley, Beth Baldys, Diane Ito & Haramandeep Singh. (2022) Solriamfetol Titration & AdministRaTion (START) in Patients With Narcolepsy. Clinical Therapeutics 44:10, pages 1356-1369.
Crossref
Yvette N. Lamb. (2020) Pitolisant: A Review in Narcolepsy with or without Cataplexy. CNS Drugs 34:2, pages 207-218.
Crossref
Maeve PascoeJames Bena & Nancy Foldvary-Schaefer. (2019) Effects of Pharmacotherapy Treatment on Patient-Reported Outcomes in a Narcolepsy and Idiopathic Hypersomnia Cohort. Journal of Clinical Sleep Medicine 15:12, pages 1799-1806.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.